Wells Fargo’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.4K Sell
517
-7,150
-93% -$185K ﹤0.01% 5430
2025
Q1
$78.2K Buy
7,667
+402
+6% +$4.1K ﹤0.01% 4775
2024
Q4
$101K Buy
7,265
+1,521
+26% +$21.2K ﹤0.01% 4707
2024
Q3
$112K Buy
5,744
+245
+4% +$4.78K ﹤0.01% 4555
2024
Q2
$102K Buy
5,499
+5,157
+1,508% +$95.9K ﹤0.01% 4570
2024
Q1
$4.8K Buy
342
+1
+0.3% +$14 ﹤0.01% 5506
2023
Q4
$2.89K Sell
341
-4
-1% -$34 ﹤0.01% 5593
2023
Q3
$3.08K Sell
345
-234
-40% -$2.09K ﹤0.01% 5660
2023
Q2
$4.99K Sell
579
-3,977
-87% -$34.3K ﹤0.01% 5774
2023
Q1
$48K Buy
4,556
+3,646
+401% +$38.4K ﹤0.01% 4887
2022
Q4
$30.9K Sell
910
-551
-38% -$18.7K ﹤0.01% 4767
2022
Q3
$70K Sell
1,461
-16
-1% -$767 ﹤0.01% 4501
2022
Q2
$84K Sell
1,477
-5,814
-80% -$331K ﹤0.01% 4481
2022
Q1
$590K Sell
7,291
-370
-5% -$29.9K ﹤0.01% 4037
2021
Q4
$1.55M Sell
7,661
-3,185
-29% -$646K ﹤0.01% 3508
2021
Q3
$2.92M Sell
10,846
-1,408
-11% -$379K ﹤0.01% 3191
2021
Q2
$3.16M Sell
12,254
-516
-4% -$133K ﹤0.01% 3137
2021
Q1
$3.83M Sell
12,770
-4,131
-24% -$1.24M ﹤0.01% 2941
2020
Q4
$4.31M Buy
16,901
+5,401
+47% +$1.38M ﹤0.01% 2862
2020
Q3
$2.86M Sell
11,500
-5,993
-34% -$1.49M ﹤0.01% 2986
2020
Q2
$6.08M Sell
17,493
-349
-2% -$121K ﹤0.01% 2261
2020
Q1
$4.78M Buy
17,842
+553
+3% +$148K ﹤0.01% 2229
2019
Q4
$5.6M Sell
17,289
-8,800
-34% -$2.85M ﹤0.01% 2442
2019
Q3
$7.13M Buy
26,089
+3,515
+16% +$960K ﹤0.01% 2202
2019
Q2
$12M Sell
22,574
-8,187
-27% -$4.37M ﹤0.01% 1816
2019
Q1
$15.5M Buy
30,761
+8,737
+40% +$4.4M ﹤0.01% 1627
2018
Q4
$10.9M Sell
22,024
-5,585
-20% -$2.75M ﹤0.01% 1785
2018
Q3
$25.2M Buy
27,609
+15,587
+130% +$14.3M 0.01% 1356
2018
Q2
$8.81M Sell
12,022
-2,479
-17% -$1.82M ﹤0.01% 2164
2018
Q1
$23.1M Buy
14,501
+3,799
+35% +$6.06M 0.01% 1366
2017
Q4
$9.59M Sell
10,702
-3,669
-26% -$3.29M ﹤0.01% 2025
2017
Q3
$5.17M Buy
14,371
+680
+5% +$245K ﹤0.01% 2475
2017
Q2
$4.02M Sell
13,691
-130
-0.9% -$38.1K ﹤0.01% 2592
2017
Q1
$4.87M Buy
13,821
+946
+7% +$333K ﹤0.01% 2436
2016
Q4
$2.37M Buy
12,875
+5,187
+67% +$954K ﹤0.01% 2989
2016
Q3
$1.98M Buy
7,688
+440
+6% +$113K ﹤0.01% 2939
2016
Q2
$1.55M Sell
7,248
-1,146
-14% -$245K ﹤0.01% 3120
2016
Q1
$1.73M Buy
8,394
+1,069
+15% +$220K ﹤0.01% 2994
2015
Q4
$1.85M Buy
7,325
+728
+11% +$184K ﹤0.01% 2992
2015
Q3
$1.09M Sell
6,597
-1,210
-15% -$199K ﹤0.01% 3365
2015
Q2
$1.47M Buy
7,807
+2,799
+56% +$525K ﹤0.01% 3269
2015
Q1
$826K Sell
5,008
-613
-11% -$101K ﹤0.01% 3583
2014
Q4
$1.31M Buy
5,621
+2,861
+104% +$665K ﹤0.01% 3282
2014
Q3
$500K Buy
2,760
+1,869
+210% +$339K ﹤0.01% 3842
2014
Q2
$172K Sell
891
-142
-14% -$27.4K ﹤0.01% 4344
2014
Q1
$188K Buy
1,033
+857
+487% +$156K ﹤0.01% 4285
2013
Q4
$30K Buy
176
+33
+23% +$5.63K ﹤0.01% 4786
2013
Q3
$22K Sell
143
-1,473
-91% -$227K ﹤0.01% 4843
2013
Q2
$280K Buy
+1,616
New +$280K ﹤0.01% 3949